18F fluciclovine not checked

Blue Earth Diagnostics

FollowEvery change as it happens, and a Monday email
Stage
No active trials
 
Next date
None yet
 
Trials
0 active
2 in total
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
How it’s given
“18F fluciclovine injection, 185 MBq (5 mCi) ± 20%, delivered as an intravenous bolus”In the company’s words, NCT04410133 on ClinicalTrials.gov
Tested for
Brain Metastases (2 trials)
Main trialPhase 3
“An open-label, single dose, single arm, prospective, multicenter Phase 3 study to establish the diagnostic performance of 18F fluciclovine positron emission tomography (PET) in detecting recurrent brain metastases after radiation therapy”In the company’s words, NCT04410133 on ClinicalTrials.gov
Other names
Axumin

Other drugs for Brain Metastases

All 58 drugs for Brain Metastases

Coming up0

No dates coming up.

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials2

TrialPhaseCompletesWhat it tests
Phase 3Completed 5 Jun 2023 Study to Establish the Diagnostic Performance of 18F Fluciclovine PET in Detecting Recurrent Brain Metastases
Phase 2Completed 31 Dec 2021 Study to Establish Image Interpretation Criteria for 18F Fluciclovine PET in Detecting Recurrent Brain Metastases (PURSUE)
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow 18F fluciclovine

Following is part of Solo: you see every change to 18F fluciclovine the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in